Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)

Clinical trial NCT05682859 · COMPLETED

Trial details

NCT number: NCT05682859
Sponsor: Jacob Pontoppidan Thyssen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hand Eczema

Start date: 2023-09-25
Primary completion: 2025-06-17
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.